Hegvik, T., Waløen, K., Pandey, S. K., Faraone, S. V., Haavik, J., & Zayats, T. (2019). Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment. Mol Psychiatry.

Hegvik, Tor-Arne, Kai Waløen, Sunil K. Pandey, Stephen V. Faraone, Jan Haavik, and Tetyana Zayats. "Druggable Genome in Attention Deficit/hyperactivity Disorder and Its Co-morbid Conditions. New Avenues for Treatment." Mol Psychiatry 2019.

Hegvik, Tor-Arne, et al. "Druggable Genome in Attention Deficit/hyperactivity Disorder and Its Co-morbid Conditions. New Avenues for Treatment." Mol Psychiatry 2019.